Aspira Women's Health (AWH) EBITDA US GAAP (year values) |
|||||||||
| FY2021 | FY2022 | FY2023 | FY2024 | FY2025 | LTM ? | CAGR 5 years ? | |||
| EBITDA, bln rub | ? | -32.3 | -30.9 | -16.5 | -16.2 | -7.91 | -8.29 | ||
| Changes by years, y/y, % | +82% | -4% | -47% | -2% | -51% | -14.9% | |||
Aspira Women's Health. EBITDA US GAAP, bln rub
Aspira Women's Health. EBITDA US GAAP, changes, %
Aspira Women's Health. EBITDA US GAAP, sum by quarters, bln rub
Aspira Women's Health (AWH) EBITDA US GAAP (quarter values) |
||||||||
| FY2025Q1 | FY2025Q2 | FY2025Q3 | FY2025Q4 | FY2026Q1 | LTM ? | |||
| EBITDA, bln rub | ? | -1.83 | -1.81 | -4.83 | 0.552 | -2.20 | -8.29 | |
| Changes by years, y/y, % | -61% | -59% | +30% | -116% | +21% | |||
| Changes by quarters, q/q, % | -47% | -1% | +167% | -111% | -499% | |||